Bioengineers at UT Dallas with collaborators at UT Southwestern Medical Center were able to create corneal tissue models and utilize them to study how damaged eyes heal. Corneal keratocytes are programmed to assist if the eye is injured. The cornea is composed of threadlike collagen fibrils, arranged in a criss-cross pattern to guide keratocytes to (Read more...)
Tag: Ophthalmology
CES 2020: EyeQue At-Home Eye Exams
At CES in Las Vegas we ran into a rep of EyeQue, a company that is revolutionizing how eye exams are conducted. Currently, most people visit a specialist, but with EyeQue’s products one can perform the exam at home on themselves and others. Here’s a rep on the floor of CES showing off all of […]
Masimo’s RD SET Sensors Now with Improved Accuracy for Neonates
Masimo has won FDA clearance for its RD SET sensors, that feature the company’s signature Measure-through Motion and Low Perfusion SET pulse oximetry, to sport much better oxygen saturation (SpO2) accuracy specs when monitoring neonatal patients. Previously, the RD SET sensors showed an approximate 3% difference in measurements at 1 standard (Read more...)
A Breakthrough Year in Retina Research
Dr Charles Wykoff highlights the many innovations in retina research in 2019, from the milestone moment of gene therapy to the diagnostic promise of artificial intelligence. Medscape Ophthalmology
FDA OKs Ophthalmic Stain for Vitreoretinal Surgery
Brilliant Blue G (0.025%) ophthalmic solution selectively stains the internal limiting membrane to distinguish it from the retina to facilitate removal. FDA Approvals
Achieving Adequate Pupil Size in Cataract Surgery
What are the best methods for managing small pupils in patients undergoing cataract surgery? Current Opinion in Ophthalmology
Blue Light Glasses: Helpful or Just Hype?
More people are turning to blue light glasses to block the light from digital screens. But do the glasses really work? WebMD Health News
MP-TSCPC: What We Do and Don’t Know
Can micropulse transscleral diode laser photocoagulation lower IOP and side effects associated with conventional transscleral diode treatment? Dr Shuchi Patel shares her personal observations. Medscape Ophthalmology
Comcast Partners with NuEyes to Make TV Accessible to People with Low Vision
In the past few years, Comcast, a television company, has been putting some serious effort into making its content more accessible to people with disabilities. It recently released its X1 eye control offering that lets users change channels, search for shows, schedule recordings of shows, and more by simply looking at specific areas of the [&hellip (Read more...)
FDA Panel Thumbs Up for Teprotumumab for Thyroid Eye Disease
FDA panel unanimously recommends approval of teprotumumab for the treatment of active thyroid eye disease. ‘I think we’re finally going to be able to get a lot of people some help,’ said one member. Medscape Medical News
Brolucizumab Gets EU Panel Backing for Wet AMD
The treatment, previously approved by the FDA, offers less-frequent injections, and efficacy proven in two head-to-head global trials. International Approvals
It’s About Time: Brolucizumab Extends Treatment Effect in Wet AMD
The latest phase 3 results show why this drug may be the promising treatment we’ve been waiting for. Medscape Ophthalmology
AI Screening for Diabetic Retinopathy Moves to Retail Clinics
The high-tech screening for diabetic retinopathy has already been added to five grocery stores in Delaware and Pennsylvania. Medscape Medical News
Peripheral Fields Key in Predicting Diabetic Retinopathy
A new artificial intelligence algorithm uses peripheral retinal field images to predict how quickly diabetic retinopathy will progress and which patients need immediate attention. Medscape Medical News
MiSight Contacts FDA Cleared to Slow Myopia in Kids
Myopia is a very common condition in children, often progressing rapidly and triggering earlier onset of other eye conditions, such as cataracts and detached retina. Cooper Vision, a company out of Lake Forest, California, just won FDA clearance for the first contact lens that can actually slow down the progression of childhood myopia. Myopia is [& (Read more...)
FDA OKs First Contact Lens to Slow Myopia in Children
MiSight (CooperVision Inc) soft, disposable contact lenses are meant to be worn daily (but not overnight) to correct nearsightedness and slow the progression of myopia in children 8 to 12 years old. FDA Approvals
Solving a Medical Mystery Crucial to Future Space Travel
Half the astronauts on the International Space Station have been held back by blurry vision, jeopardizing longer missions to Mars, and clinicians are racing to prevent the perplexing problem. Medscape Medical News
Double Trouble: 4 Things to Do in Patients With Diplopia
A guide for discerning whether the cause of new-onset diplopia is benign or potentially life-threatening. Medscape Ophthalmology
Eyevensys Non-Viral Gene Therapy for Ocular Diseases: Interview with Patricia Zilliox, CEO of Eyevensys
Eyevensys, a clinical-stage biotechnology company based in France, has developed a method to perform non-viral gene therapy in the eye, with the aim of treating ocular diseases. The system uses ocular electrotransfection to deliver therapeutic genes into the eye. Consisting of an ocular device and an electrical pulse generator, the system can deliv (Read more...)
Snubbed by Scientists, Recognized 20 Years Later
Robert Folberg’s success was 2 decades in the making after his team discovered vasculogenic mimicry. Their original report received a frosty reception, but has since been cited more than 1900 times. Medscape Medical News